ArticleWorld journal of microbiology & biotechnology2025
Curtobacterium oceanosedimentum-derived biosurfactants as eco-friendly biocontrol agent with broad-spectrum antibacterial and antifungal properties for sustainable applications.
Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Biosurfactants are eco-friendly surface-active biomolecules with diverse applications in biotechnology, agriculture, and healthcare. This study identifies Curtobacterium oceanosedimentum (C. oceanosedimentum) as a novel biosurfactants producer with potent biocontrol potential against bacterial and fungal pathogens. The present study contributes to ongoing efforts in biosurfactant research by presenting the functional attributes of C. oceanosedimentum-derived biosurfactants (COBS), characterized as a complex glycolipopeptide or lipoglycoprotein containing lipid, peptide, and carbohydrate moieties. Preliminary screening through oil spreading, drop collapse, and hemolytic assays confirmed biosurfactants production, while emulsification index assays demonstrated strong emulsifying activity, particularly with olive oil (60%), indicating broad applicability. Advanced characterization using HPTLC, FTIR, and HR-LCMS revealed the presence of amino acids, peptides, and fatty acid amides, further validating its structural complexity. Antimicrobial assays demonstrated superior efficacy of COBS, exhibiting significant antibacterial activity against Chromobacterium violaceum (24 mm) and Acinetobacter calcoaceticus (22 mm), alongside pronounced antifungal effects against Candida albicans, Fusarium proliferatum, and Penicillium purpurogenum. These findings establish COBS as a unique biosurfactants with dual antibacterial and antifungal properties, distinguishing it from previously reported biosurfactants. Its eco-friendly nature and broad-spectrum antimicrobial potential make it a promising candidate for sustainable applications in biocontrol, healthcare, and environmental remediation. Further studies on large-scale production and stability optimization will be essential for commercial applications.
Indexed as
Identifiers
40328999What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.